Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with early-treated phenylketonuria.

Saved in:

Bibliographic Details
Title:	Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with early-treated phenylketonuria.
Authors:	Griffiths, P.¹, Paterson, L.¹, Harvie, A.²
Source:	Journal of Intellectual Disability Research. Oct1995, Vol. 39 Issue 5, p365-372. 8p.
Subject Terms:	Intellectual disabilities, Mental health services, *Neuropsychology, Phenylketonuria, Amino acid metabolism disorders, Mental health of people with intellectual disabilities, Phenylalanine, Pathological psychology
Abstract:	Severe mental handicap in phenytketonuria (PKU) can be prevented if dietary treatment is implemented at birth. Controversy remains about the optimum age for terminating treatment. A group of adolescents and young adults with PKU from the West of Scotland Register was identified which had received early treatment, been well-controlled on diet, ceased treatment at 10 years old and subsequently were hyperphenylalaninaemic for 3 years or more. They were given a battery of neuropsychological tests and their results were compared with those of on-diet subjects with PKU and normal controls. The findings generally supported the view that dietary cessation at age 10 is sufficient to prevent a substantial reduction of cognitive and motor ability, and that the central nervous system is probably mature enough to withstand the toxic effects of high blood phenylalanine by then. However, there were minor indications, in keeping with Welsh et al.'s hypothesis [M.C.Welsh. B.F. Pennington. S. Ozonoff, B. Rouse & E.R.B. McCabe (1990) Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Development 61,1697–713], that subtle intellectual deficiencies might arise both during and after treatment, possibly in the realm of frontal-executive functions. [ABSTRACT FROM AUTHOR]
	Copyright of Journal of Intellectual Disability Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	Education Research Complete

Description
Abstract:	Severe mental handicap in phenytketonuria (PKU) can be prevented if dietary treatment is implemented at birth. Controversy remains about the optimum age for terminating treatment. A group of adolescents and young adults with PKU from the West of Scotland Register was identified which had received early treatment, been well-controlled on diet, ceased treatment at 10 years old and subsequently were hyperphenylalaninaemic for 3 years or more. They were given a battery of neuropsychological tests and their results were compared with those of on-diet subjects with PKU and normal controls. The findings generally supported the view that dietary cessation at age 10 is sufficient to prevent a substantial reduction of cognitive and motor ability, and that the central nervous system is probably mature enough to withstand the toxic effects of high blood phenylalanine by then. However, there were minor indications, in keeping with Welsh et al.'s hypothesis [M.C.Welsh. B.F. Pennington. S. Ozonoff, B. Rouse & E.R.B. McCabe (1990) Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Development 61,1697–713], that subtle intellectual deficiencies might arise both during and after treatment, possibly in the realm of frontal-executive functions. [ABSTRACT FROM AUTHOR]
ISSN:	09642633
DOI:	10.1111/j.1365-2788.1995.tb00540.x